Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,664 | 21,179 | 21,736 | 21,347 | 23,203 |
| Receivables | 10,670 | 11,511 | 12,002 | 12,867 | 11,135 |
| Inventories | 8,604 | 8,925 | 9,747 | 10,063 | 10,205 |
| TOTAL | $43,923 | $43,751 | $46,075 | $47,287 | $46,890 |
| Non-Current Assets | |||||
| PPE Net | 1,433 | 1,569 | 1,205 | 1,172 | 1,263 |
| Intangibles | 223,282 | 229,181 | 235,894 | 246,737 | 247,612 |
| Other Non-Current Assets | 1,886 | 1,404 | 739 | 908 | 967 |
| TOTAL | $226,601 | $232,154 | $237,838 | $248,817 | $249,842 |
| Total Assets | $270,524 | $275,905 | $283,913 | $296,104 | $296,732 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,000 | 12,000 | 12,000 | 11,250 | 10,500 |
| Accounts payable and accrued liabilities | 9,633 | 9,316 | 11,093 | 9,482 | 16,126 |
| Accrued Expenses | N/A | N/A | N/A | 4,538 | N/A |
| Other current liabilities | N/A | 901 | 1,698 | 2,350 | 2,734 |
| TOTAL | $26,367 | $27,672 | $29,922 | $33,634 | $35,096 |
| Non-Current Liabilities | |||||
| Long Term Debt | 81,295 | 84,134 | 86,970 | 90,551 | 93,380 |
| Other Non-Current Liabilities | 2,136 | 1,884 | 1,754 | 1,536 | 218 |
| TOTAL | $85,128 | $87,497 | $89,292 | $92,640 | $94,178 |
| Total Liabilities | $111,495 | $115,169 | $119,214 | $126,274 | $129,274 |
| Shareholders' Equity | |||||
| Common Shares | 266,129 | 265,917 | 265,561 | 263,275 | 259,825 |
| Retained earnings | -124,761 | -119,857 | -114,400 | -111,119 | -107,602 |
| Other shareholders' equity | 5,397 | 2,959 | 2,161 | 6,200 | 3,463 |
| TOTAL | $159,029 | $160,736 | $164,699 | $169,830 | $167,458 |
| Total Liabilities And Equity | $270,524 | $275,905 | $283,913 | $296,104 | $296,732 |